Red blood cell alloimmunization in sickle cell disease: Prevalence in 2010

Transfusion

Volumn 53, Issue 4, 2013, Pages 704-709

  Miller, Scott T ^a   Kim, Hae Young ^a   Weiner, Debra L ^a   Wager, Carrie G ^a   Gallagher, Dianne ^a   Styles, Lori A ^a   Dampier, Carlton D ^a   Roseff, Susan D ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ERYTHROCYTE ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLOIMMUNIZATION; ANTIBODY SCREENING; ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE DURATION; ERYTHROCYTE TRANSFUSION; FEASIBILITY STUDY; FEMALE; HEALTH SURVEY; HEMOGLOBIN SC DISEASE; HLA MATCHING; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; AGED; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; CHILD; CHILD, PRESCHOOL; EARLY TERMINATION OF CLINICAL TRIALS; ERYTHROCYTE TRANSFUSION; FEASIBILITY STUDIES; FEMALE; HEALTH CARE SURVEYS; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; PATIENT SELECTION; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 84876132215     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03796.x     Document Type: Article

References (36)

1. Garratty G,. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion 1997; 37: 357-61.
2. King KE, Shirey RS,. Transfusion management of patients with sickle cell disease: the continuing dilemma. Transfusion 2010; 50: 2-4.
3. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B,. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990; 322: 1617-21.
4. Westhoff CM,. The structure and function of the Rh antigen complex. Semin Hematol 2007; 44: 42-50.
5. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F,. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012.
6. Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD,. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994; 34: 562-9.
7. Ambruso DR, Githens JH, Alcorn R, Dixon DJ, Brown LJ, Vaughn WM, Hays T,. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987; 27: 94-8.
8. Lasalle-Williams M, Nuss R, Le T, Cole L, Hassell K, Murphy JR, Ambruso DR,. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 2011; 51: 1732-9.
9. Vichinsky EP, Luban NL, Wright E, Olivieri N, Driscoll C, Pegelow CH, Adams RJ,; Stroke Prevention Trial in Sickle Cell Anemia. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001; 41: 1086-92.
10. Styles L, Wager CG, Labotka RJ, Smith-Whitley K, Thompson AA, Lane PA, McMahon LE, Miller R, Roseff SD, Iyer RV, Hsu LL, Castro OL, Ataga KI, Onyekwere O, Okam M, Bellevue R, Miller ST,; for the Sickle Cell Disease Clinical Research Network (SCDCRN). Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE). Br J Haematol 2012; 157: 627-36.
11. Rosse WF, Gallagher D, Kinney TR, Castro O, Dosik H, Moohr J, Wang W, Levy PS,. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990; 76: 1431-7.
12. Lee MT, Piomelli S, Granger S, Miller ST, Harkness S, Brambilla DJ, Adams RJ,; STOP Study Investigators. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood 2006; 108: 847-52.
13. Pegelow CH, Adams RJ, McKie V, Abboud M, Berman B, Miller ST, Olivieri N, Vichinsky E, Wang W, Brambilla D,. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995; 126: 896-9.
14. Klein HG,. How safe is blood, really? Biologicals 2010; 38: 100-4.
15. Adams RJ, Brambilla D,. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005; 353: 2769-78.
16. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D,. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results ontranscranial Doppler ultrasonography. N Engl J Med 1998; 339: 5-11.
17. Emre U, Miller ST, Gutierez M, Steiner P, Rao SP, Rao M,. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr 1995; 127: 901-4.
18. Mallouh AA, Asha M,. Beneficial effect of blood transfusion in children with sickle cell chest syndrome. Am J Dis Child 1988; 142: 178-82.
19. Wayne AS, Kevy SV, Nathan DG,. Transfusion management of sickle cell disease. Blood 1993; 81: 1109-23.
20. Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B,. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood 1997; 89: 1787-92.
21. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA,. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000; 342: 1855-65.
22. Kato GJ, Gladwin MT, Steinberg MH,. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007; 21: 37-47.
23. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR,. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991; 325: 11-6.
24. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, Vera JC, Levy PS,. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994; 84: 643-9.
25. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V,. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002; 42: 37-43.
26. Chou ST, Westhoff CM,. Molecular biology of the Rh system: clinical considerations for transfusion in sickle cell disease. Hematology Am Soc Hematol Educ Program 2009; 178-84.
27. Klein H, Anstee D, editors. Mollison's blood transfusion in clinical medicine. 11th ed. Padstow, Corwall, UK: Blackwell Publishing; 2005.
28. Westhoff CM, Reid ME,. Review: the Kell, Duffy, and Kidd blood group systems. Immunohematology 2004; 20: 37-49.
29. Castro O, Sandler SG, Houston-Yu P, Rana S,. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002; 42: 684-90.
30. Afenyi-Annan A, Willis MS, Konrad TR, Lottenberg R,. Blood bank management of sickle cell patients at comprehensive sickle cell centers. Transfusion 2007; 47: 2089-97.
31. National Institutes of Health. The management of sickle cell disease. Washington, DC: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute. 2002. [cited 2012 Jul 5]. Available from: URL: http://www.nhlbi.nih. gov/health/prof/blood/sickle/sc-mngt.pdf.
32. Osby M, Shulman IA,. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 2005; 129: 190-3.
33. Afenyi-Annan A, Kail M, Combs MR, Orringer EP, Ashley-Koch A, Telen MJ,. Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease. Transfusion 2008; 48: 917-24.
34. Darbonne WC, Rice GC, Mohler MA, Apple T, Hébert CA, Valente AJ, Baker JB,. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991; 88: 1362-9.
35. Abboud MR, Taylor EC, Habib D, Dantzler-Johnson T, Jackson SM, Xu F, Laver J, Ballas SK,. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol 2000; 111: 482-90.
36. Tournamille C, Colin Y, Cartron JP, Le Van Kim C,. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995; 10: 224-8.